The Polo-like kinase 1 (PLK1) pathway is crucial for cell cycle regulation and mitotic progression, and its overexpression has been associated with poor prognosis in various cancers, including lung adenocarcinoma (LUAD) (46). Here, PLK1 is linked to cancer.